Patient Guide: A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 16 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05704049
Status: 🟢 Enrolling Now
Condition: Multiple Myeloma, Neoplasms, Plasma Cell
Phase: PHASE2

Where You Can Participate

This study is available at 16 locations across the country.

Top locations include:
  • • Wollongong, New South Wales
  • • Fitzroy, Victoria
  • • Porto Alegre, Rio Grande Do Sul
  • • And 13 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma - Join Clinical Trial NCTNCT05704049

How to Join This Clinical Trial - NCTNCT05704049

Learn how to participate in this PHASE2 trial studying an investigational therapy for Multiple Myeloma, Neoplasms, Plasma Cell. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Multiple Myeloma, Neoplasms, Plasma Cell. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Multiple Myeloma, Neoplasms, Plasma Cell
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05704049 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 16 locations. Find a study site near you:

Clinical Research Site

Wollongong, New South Wales 2500 - Australia

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Fitzroy, Victoria 3065 - Australia

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Porto Alegre, Rio Grande Do Sul 90110-270 - Brazil

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Sao Paulo, São Paulo 04537-081 - Brazil

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Sao Paulo, São Paulo 05403-000 - Brazil

Status: RECRUITING

Clinical Research Site

Brno, 62500 - Czechia

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Olomouc, 77900 - Czechia

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Ostrava - Poruba, 70852 - Czechia

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Praha 2, 12808 - Czechia

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Athens, 10676 - Greece

Status: RECRUITING

And 6 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Multiple Myeloma, Neoplasms, Plasma Cell:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships